Arpit Mittal, Payal Malhotra, Sandeep Jain, & Gauri Kapoor. (2022). Crizotinib in high risk neuroblastoma: Experience from a tertiary care cancer centre. Elsevier.
Chicago Style (17th ed.) CitationArpit Mittal, Payal Malhotra, Sandeep Jain, and Gauri Kapoor. Crizotinib in High Risk Neuroblastoma: Experience from a Tertiary Care Cancer Centre. Elsevier, 2022.
MLA (9th ed.) CitationArpit Mittal, et al. Crizotinib in High Risk Neuroblastoma: Experience from a Tertiary Care Cancer Centre. Elsevier, 2022.
Warning: These citations may not always be 100% accurate.